MedTrace Logo

Clinical Screening of Acute Ruptures of the Anterior Cruciate Ligament of the Knee

NCT03113734 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 355

Last updated 2021-04-27

No results posted yet for this study

Summary

This study develops the construction and validation of a reliable functional screening score in LCA ruptures in the immediate post-traumatic period.

This score, realizable in an emergency, would be an early warning signal requiring an emergency consultation with an orthopedic surgeon. It would be a tool for screening acute LCA ruptures at a time when ligament testing maneuvers are too painful to be contributory to the diagnosis. It would avoid a premature return to dangerous activity for the knee with a rupture of the LCA.

The other impact would be economical since it would avoid the realization of unnecessary MRI.

On the other hand, it will allow patients with LCA rupture to have faster access to MRI. The hypothesis of the study is that a validated functional score would make it possible to sort the patients in the emergencies and to prescribe the MRI only in the cases of effective rupture of the LCA.

Conditions

  • Orthopedic
  • Rupture

Interventions

OTHER

Construction and validation of a functional score

All patients will be treated at the same way: Completion of questionnaire by the physician with him. Once the consultation has been completed, the physician will issue prescriptions for the usual medical treatment, laximetry prescription (GNRB) to be performed when the knee is indolent and the prescription of the MRI to be performed .The physician will inform the patient that they should consult with the investigator's orthopedic surgeon once the results of GNRB and MRI are available.The study will end there for the patient. The surgeon will then follow his usual diagnostic procedure to decide on the future care of the patient.

Sponsors & Collaborators

  • Fondation Paul Bennetot

    collaborator OTHER

  • Clinique les Maussins

    collaborator UNKNOWN

  • Clinique Mutualiste de Lorient

    collaborator UNKNOWN

  • French Arthroscopic Society

    lead OTHER

Principal Investigators

  • Geoffroy NOURRISAT, PHD · Clinique des Maussins

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-29
Primary Completion
2021-06-29
Completion
2021-08-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03113734 on ClinicalTrials.gov